VivoSeq
Oncology

Cancer Recurrence

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cancer Recurrence is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

3

clinical trials

Unknown status1 · 33%
Active, not recruiting1 · 33%
Completed1 · 33%

Clinical Trials

Trial Activity

Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery
Unknown status·IInstitutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor·Phase 2·NCT04449289·100 enrolled
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
Active, not recruiting·SShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University·Phase 2·NCT06728631·22 enrolled
Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence
Completed·OOslo University Hospital·Phase 2·NCT05679193·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)